Tasigna Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

Asciminib Roll-over Study
Condition:   Chronic Myelogenous Leukemia Interventions:   Drug: Asciminib single agent;   Drug: Asciminib;   Drug: Imatinib;   Drug: Nilotinib;   Drug: Bosutinib;   Procedure: ECG;   Procedure: Pregnancy test Sponsor:   Novartis Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 7, 2021 Category: Research Source Type: clinical trials

KRT-232 and TKI Study in Chronic Myeloid Leukemia
Condition:   Chronic Myeloid Leukemia Interventions:   Drug: KRT-232;   Drug: Dasatinib;   Drug: Nilotinib Sponsor:   Kartos Therapeutics, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2021 Category: Research Source Type: clinical trials